Motegrity
Motegrity

1.82
For patients managing digestive health, this generic medicine triggers serotonin receptors in the gut. Aids in muscle contraction of the intestinal walls to promote regular transit.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Prucalopride succinate
Reference Brand
Prucalopride
Product Origin
Generic Alternative
Reference Manufacturer
Shire
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Selective 5-HT4 Receptor Agonist
Pharmacological Class
Prokinetic Agent
Clinical Indications
Manufacturer Description
Designed to support colonic motility to manage chronic constipation and alleviate abdominal fullness.
Mechanism of Action
Stimulates 5-HT4 receptors in gut walls, enhancing peristaltic contractions to optimize bowel movement frequency.
Route of Administration
Oral
Onset Time
24–48 hours
Duration
24 hours
Contraindications
Renal impairment requiring dialysis, Intestinal perforation, Obstructive bowel disorders
Severe Adverse Events
Severe depression and suicidal ideation — requires immediate medical attention
Common Side Effects
Headache, Nausea, Diarrhea
Uncommon Side Effects
Abdominal pain, Decreased appetite, Fatigue
Drug Interactions
Erythromycin, Ketoconazole
Pregnancy Safety Warnings
TGA Category C: Limited clinical records. Avoid in pregnancy. Breastfeeding: Expelled in low amounts.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Information related to Motegrity is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Antiviral Medication AU - Aciclovir Cold Sore Herpes Tablet